Computational studies confirm that resveratrol binds HIF-1 α with high affinity (–5.5 kcal/mol) through hydrophobic interactions, destabilizing its structure and inhibiting hypoxic signaling in pancreatic cancer [51]. Here, SETD2 is linked to pancreatic neoplasm.